Free Trial

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$120.59 -3.01 (-2.44%)
(As of 02:51 PM ET)

ADUS vs. HIMS, GH, OPCH, SHC, VCYT, BTSG, SGRY, LFST, CON, and PRVA

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

Addus HomeCare vs.

Addus HomeCare (NASDAQ:ADUS) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, community ranking, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Hims & Hers Health has a net margin of 8.19% compared to Addus HomeCare's net margin of 6.50%. Hims & Hers Health's return on equity of 10.97% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.50% 9.62% 7.37%
Hims & Hers Health 8.19%10.97%8.29%

In the previous week, Hims & Hers Health had 13 more articles in the media than Addus HomeCare. MarketBeat recorded 19 mentions for Hims & Hers Health and 6 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.06 beat Hims & Hers Health's score of 0.91 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
11 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare currently has a consensus target price of $131.63, suggesting a potential upside of 8.89%. Hims & Hers Health has a consensus target price of $21.43, suggesting a potential downside of 34.59%. Given Addus HomeCare's stronger consensus rating and higher probable upside, equities analysts plainly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.89
Hims & Hers Health
1 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.38

Addus HomeCare received 282 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.52% of users gave Addus HomeCare an outperform vote while only 38.00% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Addus HomeCareOutperform Votes
320
68.52%
Underperform Votes
147
31.48%
Hims & Hers HealthOutperform Votes
38
38.00%
Underperform Votes
62
62.00%

Addus HomeCare has higher revenue and earnings than Hims & Hers Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.06B2.07$62.52M$4.3727.66
Hims & Hers Health$872M8.21-$23.55M$0.4474.46

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Addus HomeCare has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.

Summary

Addus HomeCare beats Hims & Hers Health on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.19B$2.92B$5.22B$9.15B
Dividend YieldN/A0.35%5.72%4.01%
P/E Ratio27.6613.8497.3714.53
Price / Sales2.071.201,285.3788.30
Price / Cash24.2216.8541.4438.08
Price / Book2.773.244.754.93
Net Income$62.52M-$57.02M$119.18M$224.74M
7 Day Performance-0.34%-1.53%2.50%1.77%
1 Month Performance-2.65%3.88%1.96%9.04%
1 Year Performance31.82%12.62%32.08%28.41%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.7374 of 5 stars
$120.59
-2.4%
$131.63
+9.2%
+35.1%$2.19B$1.06B27.6034,846Analyst Downgrade
News Coverage
Positive News
HIMS
Hims & Hers Health
3.708 of 5 stars
$31.29
-2.9%
$21.43
-31.5%
+281.7%$6.84B$1.24B71.771,046Analyst Forecast
Insider Trade
Gap Down
GH
Guardant Health
3.6344 of 5 stars
$35.35
-0.7%
$40.60
+14.9%
+41.5%$4.37B$563.95M-8.401,779Short Interest ↓
Positive News
OPCH
Option Care Health
4.9765 of 5 stars
$24.12
+1.3%
$30.83
+27.8%
-21.7%$4.10B$4.78B20.007,802Analyst Forecast
Positive News
SHC
Sotera Health
4.2388 of 5 stars
$13.19
+0.2%
$16.50
+25.1%
-6.1%$3.74B$1.12B52.683,000Positive News
VCYT
Veracyte
4.4254 of 5 stars
$44.04
+2.5%
$41.25
-6.3%
+69.1%$3.41B$361.05M-286.33790Analyst Forecast
Insider Trade
Gap Down
BTSG
BrightSpring Health Services
2.3178 of 5 stars
$18.95
-1.8%
$17.21
-9.2%
N/A$3.30B$10.59B-74.2335,000Short Interest ↑
Positive News
SGRY
Surgery Partners
3.5331 of 5 stars
$24.27
+1.8%
$38.71
+59.5%
-36.6%$3.08B$2.74B-49.6713,500Analyst Forecast
News Coverage
LFST
LifeStance Health Group
1.602 of 5 stars
$7.48
-0.5%
$8.50
+13.6%
+10.6%$2.86B$1.21B-28.819,325Insider Trade
Positive News
CON
Concentra Group Holdings Parent
N/A$21.53
-1.3%
$28.50
+32.4%
N/A$2.74B$1.84B0.0011,000
PRVA
Privia Health Group
3.1052 of 5 stars
$22.18
+3.3%
$24.93
+12.4%
-1.1%$2.66B$1.72B215.601,102Positive News

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 12/5/2024 by MarketBeat.com Staff
From Our Partners